Stocks

Coronavirus pandemic: Stocks of diagnostic firms could prove safe bets

Pathology labs continue to be in concentration in watch of information pertaining to the authorities achieving out to private players for Covid-19 tests. On Sunday, two of them — Thyrocare and Metropolis Health care — acquired ultimate authorities clearance to start out tests Covid-19 among the patients.

Among corporations in the organised house, leading diagnostic chains (SRL Diagnostics, Dr Lal PathLabs, Metropolis Health care, Thyrocare and Apollo Hospitals) collectively have additional than a hundred accredited labs. This suggests that they will also be ready to quickly on-stream their labs to start out tests, say analysts.

Even so, troubles like paperwork, availability of experienced manpower, logistical infrastructure, and reimbursement for private players require to be resolved 1st for an productive rollout, say analysts at CLSA. Consequently, the developments on the similar will be viewed and the impression on earnings can be ascertained following clarity, specially with regards to reimbursements.

Thyrocare explained

Read More